Baker Hughes CEO Lorenzo Simonelli Has Sold $47.9M in BKR Stock — $23.4M in a Single Day
Baker Hughes CEO Lorenzo Simonelli sold $47.9M in BKR stock across 113 transactions, including a $23.4M block sale in July 2025. Recent February 2026 filings show 55K-share option exercises.
Lorenzo Simonelli, CEO of Baker Hughes (BKR), has sold $47.9 million in company stock across 113 insider transactions. His July 2025 block sale of 526,568 shares at $44.42 generated $23.4 million in a single transaction — nearly half his career sales total in one day.
The Numbers
| Metric | Value |
|---|---|
| Career Sell Value | $47.9M |
| Career Buy Value | $2.0M |
| Total Transactions | 113 |
| Last Transaction | 2026-02-02 |
| Shares Remaining | 55,886 |
Recent Activity
| Date | Type | Shares | Price | Est. Value |
|---|---|---|---|---|
| 2026-02-02 | Exercise | 55,885 | N/A | $0 |
| 2026-02-02 | Exercise | 55,885 | N/A | $0 |
| 2026-01-30 | Exercise | 38,116 | N/A | $0 |
| 2026-01-30 | Exercise | 38,116 | N/A | $0 |
| 2026-01-26 | Exercise | 50,857 | N/A | $0 |
Simonelli's January-February 2026 filings show repeated option exercises of 38K-56K share blocks without corresponding sales, suggesting he may be accumulating shares from vesting grants. The contrast with his massive July 2025 sell-off raises questions: is the CEO rebuilding his position after a major liquidation event, or are these exercises preceding future sales?
What It Means
The $23.4M single-day sale in July 2025 dominates Simonelli's insider trading profile. Selling half your career total in one transaction suggests either a large options tranche approaching expiration or a deliberate decision to monetize during BKR's strong energy sector performance. Baker Hughes has been a beneficiary of sustained oilfield services demand and its pivot toward energy transition technology.
With 55,886 shares remaining after the February 2026 exercises, Simonelli maintains a meaningful ~$2.5M+ stake at current prices. The exercise-without-sell pattern in early 2026 could signal renewed confidence in BKR's trajectory — or simply that the exercised options haven't entered their sale window yet. The $2M in career purchases against $47.9M in sales still shows a heavily sell-weighted profile.
What to Watch
- Whether the January-February 2026 exercised shares are sold in coming weeks
- Baker Hughes Q1 2026 earnings and oilfield services demand outlook
- Oil price trajectory and its impact on BKR's equipment orders backlog
- Other Baker Hughes insiders' activity following Simonelli's July 2025 block sale
Related Research
Explore all researchDFA — the firm that brought academic factor research to real portfolios — files 13,709 positions without a single ETF or index fund. Its Q4 2025 13F reveals a 17.9% top-5 concentration with Berkshire Hathaway, Exxon, and Visa in the top 15 — the anti-momentum portfolio built on Nobel Prize-winning research.
Mar 4, 2026
Canada's largest bank filed a U.S. 13F with 29,036 positions, three S&P 500 ETFs in its top 5, $12.5B of its own stock (RY), and $11.9B of competitor Toronto-Dominion. Netflix shares surged 893% in one quarter.
Mar 6, 2026
Ameriprise Financial's 11,224-position portfolio has the lowest top-5 concentration of any mega-filer at 14.8%. Netflix shares surged 943%, confirming an institutional consensus trade across $2.7 trillion in combined AUM. Salesforce built 82%.
Mar 6, 2026
The second Capital Group division to file a massive Netflix build in Q4 2025. Capital Research Global also doubled its Applied Materials position, holds $26B in Eli Lilly, and opened a $1B position in MicroStrategy — the Bitcoin proxy.
Mar 6, 2026
While most mega-filers lead with NVIDIA, Capital International Investors bets biggest on Broadcom at 7.7% of portfolio. They also increased Netflix shares by 710% in Q4 2025, added $3.4B in TotalEnergies, and exited Disney entirely.
Mar 6, 2026